Evidence for RNA-mediated toxicity in the fragile X-associated tremor/ataxia syndrome.

Future Neurol

Baylor College of Medicine, Interdepartmental Program in Cell & Molecular Biology, One Baylor Plaza, Room 904E, Houston, TX 77030, USA, Tel.: +1 713 798 7898, Fax.: +1 713 798 1116.

Published: November 2009

Fragile X premutation carriers are at risk for developing a late-onset, progressive neurodegenerative disorder termed fragile X-associated tremor/ataxia syndrome (FXTAS). A growing body of evidence suggests the characteristic excess CGG repeat containing FMR1 mRNA observed in premutation carriers is pathogenic and leads to clinical features of FXTAS. The current model suggests premutation mRNA transcripts can induce the formation of intranuclear inclusions by the sequestration of RNA-binding proteins and other proteins. The sequestered proteins are prevented from performing their normal functions, which is thought to lead to the neuropathology-observed FXTAS. This paper discusses the existing evidence that microsatellite expansions at the level of RNA play a role in the disease pathogenesis of FXTAS and some of the approaches that may uncover downstream effects of expanded riboCGG expression.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821051PMC
http://dx.doi.org/10.2217/fnl.09.44DOI Listing

Publication Analysis

Top Keywords

fragile x-associated
8
x-associated tremor/ataxia
8
tremor/ataxia syndrome
8
premutation carriers
8
evidence rna-mediated
4
rna-mediated toxicity
4
toxicity fragile
4
syndrome fragile
4
fragile premutation
4
carriers risk
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!